Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia

ConclusionWith BPD existing as a constant threat and there being no permanent solutions, the idea of regenerative medicine such as MSC may prove to be a breakthrough strategy when it comes to treating BPD. The success in clinical trials led to the formulation of prospective MSC-derived products such as PNEUMOSTEM ®, and there is the possibility of a stem cell medication and permanent treatment for BPD in the near future.

Source: The Clinical Respiratory Journal - September 3, 2022 Category: Respiratory Medicine Authors: Eireen Tang, Mariam Zaidi, Wen ‐Huey Lim, Vijayendran Govindasamy, Kong‐Yong Then, Khong‐Lek Then, Anjan Kumar Das, Soon‐Keng Cheong Tags: REVIEW ARTICLE Source Type: research